Fernwood Investment Management, LLC Global Blood Therapeutics, Inc. Transaction History

Fernwood Investment Management, LLC

$303 Million
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$32.4 - $68.18 $908,042 - $1.91 Million	-28,026 Reduced 13.82%	174,724 $11.9 Million
Q2 2022 Aug 11, 2022	SELL	$22.3 - $37.39 $161,117 - $270,142	-7,225 Reduced 3.44%	202,750 $6.48 Million
Q1 2022 May 03, 2022	SELL	$25.68 - $35.59 $9,630 - $13,346	-375 Reduced 0.18%	209,975 $7.27 Million
Q4 2021 Feb 09, 2022	SELL	$24.9 - $40.26 $69,097 - $111,721	-2,775 Reduced 1.3%	210,350 $6.16 Million
Q3 2021 Oct 28, 2021	BUY	$25.48 - $37.34 $127,400 - $186,700	5,000 Added 2.4%	213,125 $5.43 Million
Q2 2021 Aug 05, 2021	BUY	$32.46 - $43.42 $49,274 - $65,911	1,518 Added 0.73%	208,125 $7.29 Million
Q1 2021 May 06, 2021	BUY	$38.94 - $50.85 $192,753 - $251,707	4,950 Added 2.45%	206,607 $8.42 Million
Q4 2020 Feb 16, 2021	BUY	$37.65 - $63.77 $533,877 - $904,258	14,180 Added 7.56%	201,657 $8.73 Million
Q3 2020 Nov 03, 2020	SELL	$52.76 - $74.49 $469,564 - $662,961	-8,900 Reduced 4.53%	187,477 $10.3 Million
Q2 2020 Aug 06, 2020	SELL	$48.73 - $81.82 $415,910 - $698,333	-8,535 Reduced 4.17%	196,377 $12.4 Million
Q1 2020 Apr 30, 2020	SELL	$41.72 - $87.2 $2.22 Million - $4.63 Million	-53,100 Reduced 20.58%	204,912 $10.5 Million
Q4 2019 Feb 10, 2020	SELL	$45.7 - $81.86 $3.22 Million - $5.78 Million	-70,550 Reduced 21.47%	258,012 $20.5 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $29,794 - $38,046	657 Added 0.2%	328,562 $15.9 Million
Q2 2019 Aug 01, 2019	BUY	$52.6 - $63.29 $159,272 - $191,642	3,028 Added 0.93%	327,905 $17.2 Million
Q1 2019 May 06, 2019	SELL	$39.99 - $53.48 $1.29 Million - $1.73 Million	-32,335 Reduced 9.05%	324,877 $17.2 Million
Q4 2018 Feb 12, 2019	SELL	$31.54 - $46.67 $835,494 - $1.24 Million	-26,490 Reduced 6.9%	357,212 $14.7 Million
Q3 2018 Nov 13, 2018	BUY	$38.0 - $51.1 $1.05 Million - $1.41 Million	27,633 Added 7.76%	383,702 $14.6 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $21,672 - $28,084	560 Added 0.16%	356,069 $16.1 Million
Q1 2018 May 03, 2018	SELL	$39.6 - $65.9 $141,966 - $236,251	-3,585 Reduced 1.0%	355,509 $17.2 Million
Q4 2017 Feb 05, 2018	SELL	$29.7 - $45.7 $1.75 Million - $2.69 Million	-58,916 Reduced 14.09%	359,094 $14.1 Million
Q3 2017 Nov 09, 2017	BUY	$25.1 - $31.05 $10.5 Million - $13 Million	418,010	418,010 $13 Million

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fernwood Investment Management, LLC with notifications on news.

Account